JACQUELYN TUCKER: Open Payments
NPI 1336204833 · EASTLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 32 payments from 12 companies in 2025. Trend: 2023 $731 · 2024 $343 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $187 |
| Soleno Therapeutics, Inc. | 4 | $86 |
| Astellas Pharma US Inc | 3 | $68 |
| Novo Nordisk Inc | 3 | $50 |
| Abbott Laboratories | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 3 | $28 |
| Lilly USA, LLC | 2 | $28 |
| JAZZ PHARMACEUTICALS INC. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: AIRSUPRA, VYKAT XR, FARXIGA, Veozah, Ozempic, FREESTYLE LIBRE, TRELEGY ELLIPTA, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
